Oliver Jonas

The Translational and Regulatory Development of an Implantable Microdevice for Multiple Drug Sensitivity Measurements in Cancer Patients

Nobuhiko Hata, Adam S. Kibel, Pierpaolo Peruzzi, 2021, IEEE Transactions on Biomedical Engineering.

Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities

Robert Langer, Michael J Cima, Frank B Gertler, 2016, Clinical Cancer Research.

Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.

Robert Langer, Michael J Cima, Douglas A Lauffenburger, 2016, Cancer discovery.

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

Joe W. Gray, Damir Sudar, Mark A. Dane, 2018, Cell systems.

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors

Robert Langer, Michael J. Cima, John T. Santini, 2015, Science Translational Medicine.